Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile.
  Pharmaceutical Technology Europe E-Alert
 
22 April 2011

IN THIS ISSUE
GSK divestitures
EMA update
US patents
African drug quality

 
GSK considers OTC divestitures
GlaxoSmithKline (GSK) identified certain over-the-counter (OTC) brands in its consumer healthcare business that the company plans to divest. GSK had announced in February 2011 its intention to divest noncore OTC products as part of a strategy in its consumer healthcare business to focus on fast-growing priority brands and emerging markets. More...
 
EMA concludes class review of bisphosphonates
The EMA has concluded a class review of bisphosphonates, adopted a number of positive opinions for new medicines and revealed more about the ongoing studies regarding GlaxoSmithKline’s Pandemrix pandemic influenza vaccine and a possible link with narcolepsy. More...
 
Congress to overhaul US patent laws
US patent laws are undergoing their first large revision since the Patent Act of 1952, with the America Invents Act, introduced by Senator Leahy in January. More...
 
USP drug quality pilot underway in sub-Saharan Africa
Scientists from the national laboratories of five African nations gathered in Ghana this week to take part in technical training conducted by the US Pharmacopeia (USP) that will teach them how to detect substandard and counterfeit medicines. More...
 
Join our community on LinkedIn
Want to discuss any of this week's news stories or any other hot topics in the industry? Then why not join our group on LinkedIn? More...

Latest blog posts
Pharma and the Earth
Big pharma and buyer’s remorse
Enhancing the biosimilars industry
More blog posts

Peer-reviewed research
Delivering tamoxifen within solid lipid nanoparticles
Calculating and understanding particulate contamination risk
Improving solid dosage forms with dry granulation
More articles

Upcoming events
Pharmaceutical Compliance Forum 5th Intl Pharmaceutical Compliance Congress (2–5 May | Turkey)
Respiratory Drug Delivery Europe 2011 (3–6 May | Germany)
ExcipientFest (10–11 May | USA)
More events

Product Profiles
Oxoid

Harmonized Culture Media for MLT
Oxoid and Remel, the world leading microbiology brands of Thermo Fisher Scientific, have introduced a complete portfolio of culture media for the microbiological examination of non sterile pharmaceutical products, as recommended in the Harmonized Microbial Limit Tests chapters in the Ph. Eur, USP and JP (current editions). Read more...

 
Patheon

Protect Your Supply with Patheon
Regulatory agencies are escalating the pressure on outsourced sterile manufacturing. Establishing a back-up solution with Patheon is like having an insurance policy for your sterile product supply.
Read more...

 
Sterilin

Non-pyrogenic polystyrene containers
Sterilin non-pyrogenic polystyrene containers are certified endotoxin-free to levels below 0.01EU/ml, making them ideal for use in the pharmaceutical industry for the storage of samples, formulation work, sterility testing and endotoxin testing. Sterilized by gamma irradiation, they are available in a wide range of volumes. Read More...

 
Veltek

Veltek debuts new sterile clean room wipes,
including the industry’s first sodium
hypochlorite and hydrogen peroxide clean room wipes.
Veltek Associates, Inc., recently debuted four new sterile clean room wipes, including the HYPO-CHLOR® Saturated Sodium Hypochlorite Wipe and the STERI-PEROX®. Saturated Hydrogen Peroxide Wipe.
Read more...

 
Waters

Waters' Supercritical Fluid Extraction (SFE) systems extract chemical compounds using supercritical carbon dioxide instead of an organic solvent.
Read more...



 


Survey
Do you think that quality by design has become or is becoming an important element in the CMC requirements between a contract manufacturing organization and sponsor company?
Yes 84%
 
No 16%

This week we would like to know...

What is driving new developments in immediate-release drug delivery?

Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.

 
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, please contact us by emailing [email protected] or by mail
at Advanstar Communications Inc., Bridgegate Pavilion, 4A Chester Business Park, Wrexham Road, Chester, CH4 9QH, UK.